Prosecution Insights
Prosecution Insights
5 pending office actions • 2 clients • 5 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §112 only | 2 (40%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MATALKAH, FATIMAH KHALAF | 1 | 55.3% | +28.5% |
| UNDERDAHL, THANE E | 1 | 58.9% | +50.6% |
| KASAYAN, KATRIEL BARCELLANO | 1 | 50.0% | +0.0% |
| JOHNSON, ALLISON MARIE | 1 | 44.7% | +50.2% |
| TINSLEY, BRENDAN THOMAS | 1 | 61.9% | +70.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18504080 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | UNDERDAHL, THANE E | 23d overdue |
| 18341700 | MATERIALS AND METHODS FOR PRODUCING BLOOD PRODUCTS | KASAYAN, KATRIEL BARCELLANO | 54d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639281 | METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES | TINSLEY, BRENDAN THOMAS | 134d overdue |
| 18504080 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | UNDERDAHL, THANE E | 23d overdue |
| 18653905 | METHODS FOR CONTROLLING BLEEDING IN A SUBJECT AFFLICTED WITH HERMANSKY PUDLAK SYNDROME USING PLATELET DERIVATIVE COMPOSITIONS | MATALKAH, FATIMAH KHALAF | — |
| 17684405 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED LYMPHOCYTES AND/OR RETROVIRAL PARTICLES | JOHNSON, ALLISON MARIE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Cellphire | 3 |
| Exuma Biotech | 2 |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1699 | 1 |
| 1638 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18653905 | METHODS FOR CONTROLLING BLEEDING IN A SUBJECT AFFLICTED WITH HERMANSKY PUDLAK SYNDROME USING PLATELET DERIVATIVE COMPOSITIONS | Cellphire, Inc. | MATALKAH, FATIMAH KHALAF | §103 | Non-Final OA | — | Pending | May 02, 2024 | |
| 18504080 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | Cellphire, Inc. | UNDERDAHL, THANE E | 1699 | §103§112Other | Non-Final OA | 23d overdue | Pending | Nov 07, 2023 |
| 18341700 | MATERIALS AND METHODS FOR PRODUCING BLOOD PRODUCTS | Cellphire, Inc. | KASAYAN, KATRIEL BARCELLANO | 1634 | §103§112Other | Non-Final OA | 54d | Pending | Jun 26, 2023 |
| 17684405 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED LYMPHOCYTES AND/OR RETROVIRAL PARTICLES | Exuma Biotech Corp. | JOHNSON, ALLISON MARIE | 1638 | §112Other | Final Rejection | — | Pending | Mar 01, 2022 |
| 17639281 | METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES | Exuma Biotech Corp. | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Final Rejection | 134d overdue | Pending | Feb 28, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial